A U.S. bankruptcy judge approved a settlement requiring the Sackler family to pay up to $7 billion over 15 years, relinquish ownership of Purdue Pharma, and restructure the company into Knoa Pharma. The deal aims to address the opioid crisis and provide compensation to victims, marking a significant step in the legal saga.